Drug Type Therapeutic vaccine, mRNA vaccine |
Synonyms CV 9104, CV-9104 |
Mechanism ACP3 inhibitors(acid phosphatase 3 inhibitors), KLK3 inhibitors(Prostate-specific antigen inhibitors), MUC1 inhibitors(Mucin-1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Phase 2 | DE | 01 Jun 2014 | |
Metastatic castration-resistant prostate cancer | Phase 2 | CZ | 01 Aug 2012 | |
Metastatic castration-resistant prostate cancer | Phase 2 | FR | 01 Aug 2012 | |
Metastatic castration-resistant prostate cancer | Phase 2 | DE | 01 Aug 2012 | |
Metastatic castration-resistant prostate cancer | Phase 2 | PL | 01 Aug 2012 | |
Metastatic castration-resistant prostate cancer | Phase 2 | ES | 01 Aug 2012 | |
Metastatic castration-resistant prostate cancer | Phase 2 | SE | 01 Aug 2012 | |
Metastatic castration-resistant prostate cancer | Phase 2 | CH | 01 Aug 2012 | |
Metastatic castration-resistant prostate cancer | Phase 2 | GB | 01 Aug 2012 |